Tempest Therapeutics Inc. (TPST)
NasdaqCM: TPST
· リアルタイム株価 · USD
1.01
-0.16 (-13.68%)
終値時点: Aug 14, 2026, 3:59 PM
1.01
-0.32%
時間外: 7:36 PM
Tempest Therapeutics Inc. (TPST) Stock Price, Analysis & Data
-13.68% (1D)
TPSTについて
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and...
企業情報の全文決算サプライズ
Tempest TherapeuticsはAug 13, 2026に四半期決算を発表しました:
